Disclosures for "Scalp EEG Complexity as a Biomarker of Depression in Unilateral Temporal Lobe Epilepsy"
-
Dr. Oh has nothing to disclose.
-
The institution of Dr. Ho has received research support from NIH.
-
Dr. Deng has nothing to disclose.
-
Dr. Qing has nothing to disclose.
-
Dr. Lucas has nothing to disclose.
-
Dr. Vadera has nothing to disclose.
-
Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
-
Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care.
-
Dr. Mnatsakanyan has nothing to disclose.
-
Prof. Pizzagalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alkermes. Prof. Pizzagalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharmaceuticals. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neumora. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boehringer. Prof. Pizzagalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Circular Genomics. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Compass Pathway. Prof. Pizzagalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Engrail. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroscience Software. Prof. Pizzagalli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Psychonomic Society. Prof. Pizzagalli has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychological Association. Prof. Pizzagalli has stock in Ceretype Neuromedicine. Prof. Pizzagalli has stock in Compass Pathway. Prof. Pizzagalli has stock in Engrail Therapeutics. Prof. Pizzagalli has stock in Neumora Therapeutics. Prof. Pizzagalli has stock in Neuroscience Software.
-
The institution of Dr. Lopour has received research support from NIH. The institution of Dr. Lopour has received research support from Department of Defense. The institution of Dr. Lopour has received research support from John C. Hench Foundation. Dr. Lopour has received personal compensation in the range of $500-$4,999 for serving as a grant reviewer with NIH.
-
Dr. Jung has nothing to disclose.